Tirzepatide is approved by the US Food and Drug Administration (FDA) to reduce weight in adults with: Obesity Overweight plus at least one weight-related condition, like type 2 diabetes, high blood pressure, or high cholesterol Zepbound comes in a single-dose self-injectable pen that goes under the skin of your belly, thigh, or upper arm
*A1c measures your average blood sugar over the past 2-3 months
This short-term model suits patients needing rapid weight reduction for a specific event or as a bridge to lifestyle modification, but does not address chronic weight management
Chronic disease management drives increased sterile product usage
Recognizing these conditions and knowing how to manage them can help prevent more serious health issues
Why Choose Telehealth for Weight Loss Choosing telehealth for your weight loss journey offers unmatched flexibility and accessibility